Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.

@article{Dimopoulos2004TreatmentOO,
  title={Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.},
  author={Meletios Athanasios Dimopoulos and Christos Papadimitriou and Georgios Hamilos and Eleni Efstathiou and Georgios Vlahos and Alexandros J Rodolakis and Gerassimos Aravantinos and Haralambos P. Kalofonos and Charalambos Kouroussis and Dimitra Gika and Dimosthenis Vasilios Skarlos and Aristotelis Bamias},
  journal={Gynecologic oncology},
  year={2004},
  volume={95 3},
  pages={695-700}
}
BACKGROUND Ovarian germ cell tumors (OGCT) are highly curable when treated with cytoreductive surgery and platinum-based chemotherapy. We evaluated the safety and activity of a 3-day modified bleomycin, etoposide, and cisplatinum (mBEP) regimen in patients with OGCT. PATIENTS AND METHODS Patients with FIGO stages I-IV OGCT were treated with three (stages I-III complete resection) or four cycles (incomplete resection or stage IV) of bleomycin 15 mg iv, etoposide 120 mg/m(2) iv, and cisplatin… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…